Used in research and therapeutic development for targeting transforming growth factor-beta 1 (TGF-β1), this antibody helps modulate immune responses and fibrotic processes. It is applied in studies related to cancer, where TGF-β1 signaling contributes to tumor progression and immune evasion. It also supports investigations into fibrotic diseases such as pulmonary fibrosis, liver fibrosis, and renal fibrosis by blocking the activity of TGF-β1. In immunology, it serves as a tool to understand regulatory T cell function and immune suppression mechanisms. Its high specificity makes it valuable in assay development, target validation, and as a reference standard in preclinical studies.